Results 181 to 190 of about 408,844 (306)

How unequally is consumption of products harmful to health distributed between Iranian households? [PDF]

J Health Popul Nutr
Moeeni M, Arjvand F, Ponnet K, Nosratnejad S.   +3 more
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Assessing the costs of antenatal care in Eastern Ethiopia: implications for improving the free maternity services policy. [PDF]

Health Policy Plan
Tolossa T, Gold L, Lau EHY, Dheresa M, Abimanyi-Ochom J.   +4 more
europepmc   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Catastrophic health care expenditure among older people with non-communicable diseases in 11 European Union Member States. [PDF]

PLoS One
Kutluer S, Pavlova M, Groot W.
europepmc   +1 more source

Paying for hospital care in seven central and Eastern European countries - a comparative analysis. [PDF]

Health Econ Rev
Dubas-Jakóbczyk K, Davidovics K, Dimova A, Habicht T, Hroboň P, Imre L, Kasekamp K, Minev M, Murauskienė L, Smatana M, Rethazi G, Szalayova A, Szetela A, Šlegerová L, Topór-Mądry R.   +14 more
europepmc   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Public spending on immunisation in Poland. [PDF]

Front Public Health
Seweryn M, Augustyńska J, Kopel J, Jaworski R, Wójcik A, Paradowska-Stankiewicz I, Czech M.   +6 more
europepmc   +1 more source

Precision medicine in paediatrics: Progress and priorities

British Journal of Clinical Pharmacology, EarlyView.
Precision medicine is revolutionizing personalized healthcare, advancing both diagnostics and therapeutics at an unprecedented pace. Reviewing the paediatric applications of pharmacometrics, pharmacogenomics and advanced therapy medicinal products highlights not only the relevance of these exciting innovations to frontline care but also the significant
Nicola Husain, Claire Booth, Joseph F. Standing, Charlotte I. S. Barker   +3 more
wiley   +1 more source

THEORIZATION OF THE BUDGETING FOR MILITARY EXPENDITURES

Scientific Notes of Ostroh Academy National University, "Economics" Series, 2019
openaire   +2 more sources